| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/1999 | EP0929555A1 25-methylene and 24,25-epoxy marcfortines and paraherquamides |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929553A1 Pyrimidine derivatives and processes for the preparation thereof |
| 07/21/1999 | EP0929552A1 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 07/21/1999 | EP0929550A1 $i(N)-(BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND APPLICATION IN THERAPEUTICS |
| 07/21/1999 | EP0929549A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
| 07/21/1999 | EP0929547A1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants |
| 07/21/1999 | EP0929545A1 Tricyclic inhibitors of farnesyl protein transferase |
| 07/21/1999 | EP0929544A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929538A1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 07/21/1999 | EP0929537A1 Troponyl piperazines as selective dopamine d4 receptor ligands |
| 07/21/1999 | EP0929534A1 Trycyclic compounds as prostaglandin i 2? receptor agonists |
| 07/21/1999 | EP0929533A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929529A2 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed et a?/et b? endothelin receptor antagonists |
| 07/21/1999 | EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/21/1999 | EP0929526A1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 07/21/1999 | EP0929525A2 Novel heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929522A1 Insect-repellent formulations |
| 07/21/1999 | EP0929521A1 Nmda (n-methyl-d-aspartate) antagonists |
| 07/21/1999 | EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 07/21/1999 | EP0929517A1 Hydroxamic acid derivatives |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929515A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 07/21/1999 | EP0929323A1 Implantable acrylamide copolymer hydrogel for therapeutic uses |
| 07/21/1999 | EP0929309A1 Pharmaceutical composition containing a mixed extract of phellodendron amurense ruprecht cortex and patrinia scabiosaefolia fisch. for treatment of hepatitis c |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0929305A1 Use of vitamin d analogs for the treatment of arthritic disease |
| 07/21/1999 | EP0929304A1 Prevention of ovarian cancer by administration of progestin products |
| 07/21/1999 | EP0929303A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929301A2 Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | EP0929299A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS |
| 07/21/1999 | EP0929298A1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 07/21/1999 | EP0929295A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 07/21/1999 | EP0929293A1 Liposomes containing a cisplatin compound |
| 07/21/1999 | EP0929292A1 Method and composition for rewetting contact lenses and relieving eye dryness |
| 07/21/1999 | EP0929218A2 P2y receptor antagonists |
| 07/21/1999 | EP0929217A1 Sordarin derivatives |
| 07/21/1999 | EP0929216A1 Method of treating post menopausal diseases, including osteoporosis |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | EP0759025B1 Amide derivatives and their therapeutic use |
| 07/21/1999 | EP0750621B1 Heterocyclic compounds, their preparation and use |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |
| 07/21/1999 | EP0743959B1 Galactomannan products and compositions containing the same |
| 07/21/1999 | EP0720474B1 Volatile active substance containing plaster that may be produced without solvents |
| 07/21/1999 | EP0714411B1 Process for obtaining mucoadhesive starch |
| 07/21/1999 | EP0691327B1 Amine derivative and dermatologic preparation containing the same |
| 07/21/1999 | EP0609441B1 Oxazolidone derivatives as monoamine oxidase inhibitors |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223660A Method and compounds for curing diseases caused by mutations |
| 07/21/1999 | CN1223659A Fused imidazopyridine derivatives as antihyperlipidemic agents |
| 07/21/1999 | CN1223656A Spiro-piperidine derivatives and their use as therapeutic agents |
| 07/21/1999 | CN1223655A 1-methylcarbapenem derivatives |
| 07/21/1999 | CN1223654A N-[4-(heteroarylmethyl) phenyl]-heteroarylamines |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223650A Piperidines and pyrrolidines |
| 07/21/1999 | CN1223649A Quinolone carboxylic acids substituted by 7-(3-vinyl-1,4-piperazine-1-yl) |
| 07/21/1999 | CN1223648A Novel thiophene derivatives and drug compositions containing the same |
| 07/21/1999 | CN1223643A Prenyl transferase inhibitors |
| 07/21/1999 | CN1223642A Inhibitors of prenyl transferases |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/21/1999 | CN1223640A Substituted N-(4-pyridyl)-thiomides with pesticide activity |
| 07/21/1999 | CN1223637A Phenylalamine derivatives as integrin inhibitors |
| 07/21/1999 | CN1223592A Fluoro labelled anthracyclinone and anthracycline derivatives |
| 07/21/1999 | CN1223585A Progestational hormone-anti-progestational hormone medicine method |
| 07/21/1999 | CN1223584A Topical gel composition containing a combination of an said and a xanthine derivative |
| 07/21/1999 | CN1223583A Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |
| 07/21/1999 | CN1223582A Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 07/21/1999 | CN1223581A Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 07/21/1999 | CN1223580A Use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease |
| 07/21/1999 | CN1223579A Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 07/21/1999 | CN1223578A Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) |
| 07/21/1999 | CN1223577A Anticonvulsant derivatives useful in treating psoriasis |
| 07/21/1999 | CN1223576A Veterinary use of a pleuromutilin derivative |
| 07/21/1999 | CN1223575A Treating urinary incontinence using (S)-oxybutynin and (S)-desethyloxybutynin |
| 07/21/1999 | CN1223574A Isobutylgaba and its derivatives for the treatment of pain |
| 07/21/1999 | CN1223546A Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 07/21/1999 | CN1223262A Inclusion and resolution preparation process of optical purity benzimidazoles medicines resisting peptic ulcer |
| 07/21/1999 | CN1223261A Novel 2-thiosubstituted carbapenems |
| 07/21/1999 | CN1223259A Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof |
| 07/21/1999 | CN1223258A Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as effective ingredient |
| 07/21/1999 | CN1223257A Preparation of 3,4,4-Trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
| 07/21/1999 | CN1223256A Biologically active ureido derivatives useful as antimetastatic agents |
| 07/21/1999 | CN1223116A Enteric soluble azithromycin preparation |
| 07/21/1999 | CN1223115A Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor |
| 07/21/1999 | CN1223114A Rutin and compound rutin mixture for hemostasis |
| 07/21/1999 | CN1044249C Matrix metalloprotease inhibitors |
| 07/21/1999 | CN1044247C Penicillic olefin derivant and preparation process and use thereof |
| 07/21/1999 | CN1044246C Bicyclic beta-lactam/p-hydroxy benzoate complexes |
| 07/21/1999 | CN1044245C Tricyclic dicarbonyl derivatives, medicinal compositions and use thereof |
| 07/21/1999 | CN1044244C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity |
| 07/21/1999 | CN1044243C Biphenyl-substituted quinoline derivatives, their medicinal composition and use thereof |
| 07/21/1999 | CN1044242C Heterocyclic-cyclic amine derivatives |
| 07/21/1999 | CN1044239C Sulfonylurea derivatives, method for prepn. of same and use thereof |
| 07/21/1999 | CN1044237C 4,1-benzoxazep in derivatives and their use |
| 07/21/1999 | CN1044236C Oxazolidinone antimicrobials containing substituted diazine moieties |